You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Reimbursement news and insurance coverage updates.
New CMS billing rules and the rise of COVID-19 case numbers makes managing SARS-CoV-2 test turnaround times even more urgent for clinical laboratories.
The company's AlloSure Kidney test received coverage, along with its AlloSure Heart test when used with the firm's AlloMap test.
Novitas added multiple leukemia biomarkers to its coverage determination, as well as the ThyGeNEXT molecular panel.
Another owner of the lab also received kickbacks from third parties for referring individuals to those parties totaling $441,646.
The tests are covered when the patient has a personal history of melanoma and the test has demonstrated clinical and analytical validity.
